Review



phospho src tyr416  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    Cell Signaling Technology Inc phospho src tyr416
    Phospho Src Tyr416, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 2356 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tyr416/Phospho-Src+Family+(Tyr416)+Antibody/us12594421-308-66-69
    Average 96 stars, based on 2356 article reviews
    phospho src tyr416 - by Bioz Stars, 2026-09
    96/100 stars

    Images

    Related Articles

    Membrane:

    Article Title: Taxifolin as a Major Bioactive Compound in the Vasorelaxant Effect of Different Pigmented Rice Bran Extracts
    Article Snippet: .. Subsequently, separated proteins were transferred to a polyvinylidene difluoride (PVDF) membrane at 100 V for 2 h. Next, the membranes were blocked at room temperature in TBS using bovine serum albumin in 0.1% Tween 20 for 1 h. To detect proteins, membranes were incubated with the respective primary antibody: eNOS phosphorylated at Ser1127 [p-eNOS (Ser1177)] (1:1000, Cell Signaling Technology, MA, United States), Src phosphorylated at Tyr416 [p-Src (Tyr416)] (1:1000, Cell Signaling Technology, MA, United States), and β-tubulin (1:1000, Cell Signaling Technology, MA, United States) overnight at 4°C. .. After washing, membranes were further incubated with the appropriate horseradish peroxidase-conjugated anti-mouse or anti-rabbit immunoglobulin G (1:2000, Cell Signaling Technology, MA, United States) and developed using an enhanced chemiluminescence (ECL) detection kit.

    Incubation:

    Article Title: Taxifolin as a Major Bioactive Compound in the Vasorelaxant Effect of Different Pigmented Rice Bran Extracts
    Article Snippet: .. Subsequently, separated proteins were transferred to a polyvinylidene difluoride (PVDF) membrane at 100 V for 2 h. Next, the membranes were blocked at room temperature in TBS using bovine serum albumin in 0.1% Tween 20 for 1 h. To detect proteins, membranes were incubated with the respective primary antibody: eNOS phosphorylated at Ser1127 [p-eNOS (Ser1177)] (1:1000, Cell Signaling Technology, MA, United States), Src phosphorylated at Tyr416 [p-Src (Tyr416)] (1:1000, Cell Signaling Technology, MA, United States), and β-tubulin (1:1000, Cell Signaling Technology, MA, United States) overnight at 4°C. .. After washing, membranes were further incubated with the appropriate horseradish peroxidase-conjugated anti-mouse or anti-rabbit immunoglobulin G (1:2000, Cell Signaling Technology, MA, United States) and developed using an enhanced chemiluminescence (ECL) detection kit.

    Phospho-proteomics:

    Article Title: Roles of adenosine A 1 receptors in the regulation of SFK activity in the rat forebrain
    Article Snippet: Src , Recombinant fusion protein corresponding to residues 1‐110 of human Src , Cell Signaling Technology, mouse monoclonal, 2110, AB_2106058 , 1 , 3% Nonfat milk‐PBS 0.1% Tween‐20. .. pY416 , A synthetic phosphopeptide corresponding to residues surrounding Tyr416 of human Src , Cell Signaling Technology, rabbit polyclonal, 6943, AB_10013641 , 1 , 3% Nonfat milk‐PBS 0.1% Tween‐20. ..

    other:

    Article Title: Oxidation of KCNB1 channels in the human brain and in mouse model of Alzheimer’s disease
    Article Snippet: Src (clone 2108), phospho-Src at tyr416 (clone 2101), FAK (clone 3285), and phospho-FAK at tyr397 (clone 3283) antibodies were purchased from Cell Signaling Technology (Danvers, MA).



    Similar Products

    phospho src tyr416  (Cell Signaling Technology Inc)
    96
    Cell Signaling Technology Inc phospho src tyr416
    Phospho Src Tyr416, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tyr416/Phospho-Src+Family+(Tyr416)+Antibody/us12594421-308-66-69
    Average 96 stars, based on 1 article reviews
    phospho src tyr416 - by Bioz Stars, 2026-09
    96/100 stars
    		  Buy from Supplier
    phospho src family tyr416 d49g4 rabbit mab  (Cell Signaling Technology Inc)
    86
    Cell Signaling Technology Inc phospho src family tyr416 d49g4 rabbit mab
    A Western blot analysis of the oral squamous carcinoma cell lines to monitor numerous signaling pathways. The phosphorylated and total protein levels were determined as indicated. B Cell viability (%) of the oral squamous carcinoma cell lines treated with each Src inhibitor for 72 h. Viability was measured using CellTiter-Glo, and values are indicated relative to the 1% dimethyl sulfoxide (DMSO) control. Data represent mean ± standard deviation from three independent experiments (n = 3). C IC50 curves of the oral squamous carcinoma cell lines treated with each Src inhibitor for 36 h. Viability was measured using CellTiter-Glo and normalized to that of the 1% DMSO control. Values represent the mean of n = 3. D, E Western blot analysis of the oral squamous carcinoma cell lines to investigate Src (D) and MAPK (E) activity induced by different Src inhibitors. Oral squamous carcinoma cell lines were treated with an Src inhibitor for 18 h, followed by western blot analysis. D indicates the Src phosphorylation <t>(Tyr416),</t> and E reveals MAPK pathway-related proteins. Supplementary Table S1 lists the concentrations of the Src inhibitors used.
    Phospho Src Family Tyr416 D49g4 Rabbit Mab, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tyr416/bio_rxiv__64898__2026__04__02__716058-74-6-39
    Average 86 stars, based on 1 article reviews
    phospho src family tyr416 d49g4 rabbit mab - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    antibodies phospho src family tyr416  (Cell Signaling Technology Inc)
    96
    Cell Signaling Technology Inc antibodies phospho src family tyr416
    A Western blot analysis of the oral squamous carcinoma cell lines to monitor numerous signaling pathways. The phosphorylated and total protein levels were determined as indicated. B Cell viability (%) of the oral squamous carcinoma cell lines treated with each Src inhibitor for 72 h. Viability was measured using CellTiter-Glo, and values are indicated relative to the 1% dimethyl sulfoxide (DMSO) control. Data represent mean ± standard deviation from three independent experiments (n = 3). C IC50 curves of the oral squamous carcinoma cell lines treated with each Src inhibitor for 36 h. Viability was measured using CellTiter-Glo and normalized to that of the 1% DMSO control. Values represent the mean of n = 3. D, E Western blot analysis of the oral squamous carcinoma cell lines to investigate Src (D) and MAPK (E) activity induced by different Src inhibitors. Oral squamous carcinoma cell lines were treated with an Src inhibitor for 18 h, followed by western blot analysis. D indicates the Src phosphorylation <t>(Tyr416),</t> and E reveals MAPK pathway-related proteins. Supplementary Table S1 lists the concentrations of the Src inhibitors used.
    Antibodies Phospho Src Family Tyr416, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tyr416/Phospho-Src+Family+(Tyr416)+Antibody/pm41914886-205-7-11
    Average 96 stars, based on 1 article reviews
    antibodies phospho src family tyr416 - by Bioz Stars, 2026-09
    96/100 stars
    		  Buy from Supplier
    phospho c src tyr416 d49g4 cell signaling technology  (Cell Signaling Technology Inc)
    86
    Cell Signaling Technology Inc phospho c src tyr416 d49g4 cell signaling technology
    A Western blot analysis of the oral squamous carcinoma cell lines to monitor numerous signaling pathways. The phosphorylated and total protein levels were determined as indicated. B Cell viability (%) of the oral squamous carcinoma cell lines treated with each Src inhibitor for 72 h. Viability was measured using CellTiter-Glo, and values are indicated relative to the 1% dimethyl sulfoxide (DMSO) control. Data represent mean ± standard deviation from three independent experiments (n = 3). C IC50 curves of the oral squamous carcinoma cell lines treated with each Src inhibitor for 36 h. Viability was measured using CellTiter-Glo and normalized to that of the 1% DMSO control. Values represent the mean of n = 3. D, E Western blot analysis of the oral squamous carcinoma cell lines to investigate Src (D) and MAPK (E) activity induced by different Src inhibitors. Oral squamous carcinoma cell lines were treated with an Src inhibitor for 18 h, followed by western blot analysis. D indicates the Src phosphorylation <t>(Tyr416),</t> and E reveals MAPK pathway-related proteins. Supplementary Table S1 lists the concentrations of the Src inhibitors used.
    Phospho C Src Tyr416 D49g4 Cell Signaling Technology, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tyr416/10__3390_slash_cancers18071082-84-3-6
    Average 86 stars, based on 1 article reviews
    phospho c src tyr416 d49g4 cell signaling technology - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    cell signaling technology 2101  (Cell Signaling Technology Inc)
    96
    Cell Signaling Technology Inc cell signaling technology 2101
    A Western blot analysis of the oral squamous carcinoma cell lines to monitor numerous signaling pathways. The phosphorylated and total protein levels were determined as indicated. B Cell viability (%) of the oral squamous carcinoma cell lines treated with each Src inhibitor for 72 h. Viability was measured using CellTiter-Glo, and values are indicated relative to the 1% dimethyl sulfoxide (DMSO) control. Data represent mean ± standard deviation from three independent experiments (n = 3). C IC50 curves of the oral squamous carcinoma cell lines treated with each Src inhibitor for 36 h. Viability was measured using CellTiter-Glo and normalized to that of the 1% DMSO control. Values represent the mean of n = 3. D, E Western blot analysis of the oral squamous carcinoma cell lines to investigate Src (D) and MAPK (E) activity induced by different Src inhibitors. Oral squamous carcinoma cell lines were treated with an Src inhibitor for 18 h, followed by western blot analysis. D indicates the Src phosphorylation <t>(Tyr416),</t> and E reveals MAPK pathway-related proteins. Supplementary Table S1 lists the concentrations of the Src inhibitors used.
    Cell Signaling Technology 2101, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tyr416/Phospho-Src+Family+(Tyr416)+Antibody/pm41882003-400-96-96
    Average 96 stars, based on 1 article reviews
    cell signaling technology 2101 - by Bioz Stars, 2026-09
    96/100 stars
    		  Buy from Supplier
    anti phospho src tyr416  (Cell Signaling Technology Inc)
    96
    Cell Signaling Technology Inc anti phospho src tyr416
    A Western blot analysis of the oral squamous carcinoma cell lines to monitor numerous signaling pathways. The phosphorylated and total protein levels were determined as indicated. B Cell viability (%) of the oral squamous carcinoma cell lines treated with each Src inhibitor for 72 h. Viability was measured using CellTiter-Glo, and values are indicated relative to the 1% dimethyl sulfoxide (DMSO) control. Data represent mean ± standard deviation from three independent experiments (n = 3). C IC50 curves of the oral squamous carcinoma cell lines treated with each Src inhibitor for 36 h. Viability was measured using CellTiter-Glo and normalized to that of the 1% DMSO control. Values represent the mean of n = 3. D, E Western blot analysis of the oral squamous carcinoma cell lines to investigate Src (D) and MAPK (E) activity induced by different Src inhibitors. Oral squamous carcinoma cell lines were treated with an Src inhibitor for 18 h, followed by western blot analysis. D indicates the Src phosphorylation <t>(Tyr416),</t> and E reveals MAPK pathway-related proteins. Supplementary Table S1 lists the concentrations of the Src inhibitors used.
    Anti Phospho Src Tyr416, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tyr416/Phospho-Src+Family+(Tyr416)+Rabbit+mAb/pm41866450-70-43-49
    Average 96 stars, based on 1 article reviews
    anti phospho src tyr416 - by Bioz Stars, 2026-09
    96/100 stars
    		  Buy from Supplier
    c src family phospho tyr416  (Cell Signaling Technology Inc)
    96
    Cell Signaling Technology Inc c src family phospho tyr416
    A Western blot analysis of the oral squamous carcinoma cell lines to monitor numerous signaling pathways. The phosphorylated and total protein levels were determined as indicated. B Cell viability (%) of the oral squamous carcinoma cell lines treated with each Src inhibitor for 72 h. Viability was measured using CellTiter-Glo, and values are indicated relative to the 1% dimethyl sulfoxide (DMSO) control. Data represent mean ± standard deviation from three independent experiments (n = 3). C IC50 curves of the oral squamous carcinoma cell lines treated with each Src inhibitor for 36 h. Viability was measured using CellTiter-Glo and normalized to that of the 1% DMSO control. Values represent the mean of n = 3. D, E Western blot analysis of the oral squamous carcinoma cell lines to investigate Src (D) and MAPK (E) activity induced by different Src inhibitors. Oral squamous carcinoma cell lines were treated with an Src inhibitor for 18 h, followed by western blot analysis. D indicates the Src phosphorylation <t>(Tyr416),</t> and E reveals MAPK pathway-related proteins. Supplementary Table S1 lists the concentrations of the Src inhibitors used.
    C Src Family Phospho Tyr416, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tyr416/Phospho-Src+Family+(Tyr416)+Rabbit+mAb/pm41871717-58-48-63
    Average 96 stars, based on 1 article reviews
    c src family phospho tyr416 - by Bioz Stars, 2026-09
    96/100 stars
    		  Buy from Supplier
    p src  (Cell Signaling Technology Inc)
    96
    Cell Signaling Technology Inc p src
    A Western blot analysis of the oral squamous carcinoma cell lines to monitor numerous signaling pathways. The phosphorylated and total protein levels were determined as indicated. B Cell viability (%) of the oral squamous carcinoma cell lines treated with each Src inhibitor for 72 h. Viability was measured using CellTiter-Glo, and values are indicated relative to the 1% dimethyl sulfoxide (DMSO) control. Data represent mean ± standard deviation from three independent experiments (n = 3). C IC50 curves of the oral squamous carcinoma cell lines treated with each Src inhibitor for 36 h. Viability was measured using CellTiter-Glo and normalized to that of the 1% DMSO control. Values represent the mean of n = 3. D, E Western blot analysis of the oral squamous carcinoma cell lines to investigate Src (D) and MAPK (E) activity induced by different Src inhibitors. Oral squamous carcinoma cell lines were treated with an Src inhibitor for 18 h, followed by western blot analysis. D indicates the Src phosphorylation <t>(Tyr416),</t> and E reveals MAPK pathway-related proteins. Supplementary Table S1 lists the concentrations of the Src inhibitors used.
    P Src, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tyr416/Phospho-Src+Family+(Tyr416)+Antibody/pm41858068-64-44-47
    Average 96 stars, based on 1 article reviews
    p src - by Bioz Stars, 2026-09
    96/100 stars
    		  Buy from Supplier

    Image Search Results


    A Western blot analysis of the oral squamous carcinoma cell lines to monitor numerous signaling pathways. The phosphorylated and total protein levels were determined as indicated. B Cell viability (%) of the oral squamous carcinoma cell lines treated with each Src inhibitor for 72 h. Viability was measured using CellTiter-Glo, and values are indicated relative to the 1% dimethyl sulfoxide (DMSO) control. Data represent mean ± standard deviation from three independent experiments (n = 3). C IC50 curves of the oral squamous carcinoma cell lines treated with each Src inhibitor for 36 h. Viability was measured using CellTiter-Glo and normalized to that of the 1% DMSO control. Values represent the mean of n = 3. D, E Western blot analysis of the oral squamous carcinoma cell lines to investigate Src (D) and MAPK (E) activity induced by different Src inhibitors. Oral squamous carcinoma cell lines were treated with an Src inhibitor for 18 h, followed by western blot analysis. D indicates the Src phosphorylation (Tyr416), and E reveals MAPK pathway-related proteins. Supplementary Table S1 lists the concentrations of the Src inhibitors used.

    Journal: bioRxiv

    Article Title: Heterogeneous Sensitivity to Src Inhibitors in Oral Squamous Cell Carcinoma and Its Implications for Combination Therapy with Cisplatin

    doi: 10.64898/2026.04.02.716058

    Figure Lengend Snippet: A Western blot analysis of the oral squamous carcinoma cell lines to monitor numerous signaling pathways. The phosphorylated and total protein levels were determined as indicated. B Cell viability (%) of the oral squamous carcinoma cell lines treated with each Src inhibitor for 72 h. Viability was measured using CellTiter-Glo, and values are indicated relative to the 1% dimethyl sulfoxide (DMSO) control. Data represent mean ± standard deviation from three independent experiments (n = 3). C IC50 curves of the oral squamous carcinoma cell lines treated with each Src inhibitor for 36 h. Viability was measured using CellTiter-Glo and normalized to that of the 1% DMSO control. Values represent the mean of n = 3. D, E Western blot analysis of the oral squamous carcinoma cell lines to investigate Src (D) and MAPK (E) activity induced by different Src inhibitors. Oral squamous carcinoma cell lines were treated with an Src inhibitor for 18 h, followed by western blot analysis. D indicates the Src phosphorylation (Tyr416), and E reveals MAPK pathway-related proteins. Supplementary Table S1 lists the concentrations of the Src inhibitors used.

    Article Snippet: The following primary antibodies were used: Phospho-Src Family (Tyr416) (D49G4) Rabbit mAb (#6943), Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) (D13.14.4E) XP Rabbit mAb (#4370), Phospho-p38 MAPK (Thr180/Tyr182) (D3F9) XP Rabbit mAb (#4511), and Phospho-SAPK/JNK (Thr183/Tyr185) (81E11) Rabbit mAb (#4668) (all from Cell Signaling Technology).

    Techniques: Western Blot, Protein-Protein interactions, Control, Standard Deviation, Activity Assay, Phospho-proteomics